Michael Iuvone

The results from the standpoint of the graft taking and surviving without any signs of any kind of toxicity or tumorigenicity are very positive, but the weakness is, they only had one patient, and it's very difficult to make any conclusions from one patient.

The standard of care in most cases is to give injections of drugs that inhibit the growth hormones that is called vascular epithelial growth factor, or VEGF, for most people, it at least slows the progression and in some cases actually improves visual acuity.